Meeting
2020 Gastrointestinal Cancers Symposium
Association of neutrophil, platelet, and lymphocyte ratios with prognosis in metastatic pancreatic cancer.
Authors
Jessica Allen
University of Kansas Medical Center, Kansas City, KS
Jessica Allen , Colin Cernik , Suhaib Bajwa , Anwaar Saeed , Anup Kasi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 767)
Abstract #
767
Poster Bd #
N12
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
The predictive value of hematological markers in renal cell carcinoma.
First Author: Omar Al Ta'ani
Poster
2018 Gastrointestinal Cancers Symposium
Correlation of neutrophil lymphocyte ratio, platelet lymphocyte ratio and rate of change of CA 19.9 in predicting outcome for metastatic pancreatic cancer.
First Author: Andrew Peter Dean
Poster
2023 ASCO Annual Meeting
FOOTPATH: A randomized, open-label phase-2 study of liposomal irinotecan + 5-FU and folinic acid (NAPOLI) versus sequential NAPOLI and mFOLFOX6 versus gemcitabine/nab-paclitaxel in treatment-naïve metastatic pancreatic cancer (mPDAC).
First Author: Benedikt Westphalen
Poster
2020 Gastrointestinal Cancers Symposium
Evaluation of the ratio of plasma fibrinogen to platelet in resectable pancreatic cancer.
First Author: Yusuke Arakawa